Schrodinger, Inc. - Common Stock — Balance Sheet (NASDAQ:SDGR) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 746.26 M756.49 M688.59 M802.96 M823.23 M726.16 M Total liabilities 122.24 M199.4 M240.68 M254.4 M401.78 M362.11 M Total equity 624.02 M557.09 M447.9 M548.56 M421.44 M364.05 M Total liabilities & shareholders' equities 746.26 M756.49 M688.59 M802.96 M823.23 M726.16 M Total debt —————— Net debt ——————

News

Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field (SDGR)

Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength?

AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL)

Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Schrödinger, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:SDGR) 2026-05-06

Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates

AI Revolutionizing Biopharma: Faster, Better, Cheaper (NYSEARCA:XLV)

Recursion Pharmaceuticals May Be Losing Ground To Its Peers (NASDAQ:RXRX)

Schrodinger: AI Threat Is Looming Large (NASDAQ:SDGR)

Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Rose the dog might have just heralded the age of programmable medicine — and here are the stocks that benefit